Valuation
Is the price right?2/2 inputs reported · High confidence
Weaker than most peers on:
- ▼ P/B
- ▼ Earnings yield
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Nov 3, 2026
2/2 inputs reported · High confidence
Weaker than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Close to the peer norm on every measure.
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Stronger than most peers on:
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Revenue (12 months) | 2.3B USD | 2.3B USD | +1.3% |
| Net income (12 months) | 668.6M USD | 683.7M USD | +2.3% |
| Free cash flow (12 months) | 663.1M USD | 541.5M USD | −18.3% |
| Cash | 7.1B USD | 6.5B USD | −9.5% |
| Shares outstanding | 62.8M | 62.1M | −1.0% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Net margin | 32.3% | 34.1% | 30.1% | 28.2% | 29.0% | ▲ 0.8 pts |
| Return on assets (ROA) | 0.9% | 1.1% | 1.2% | 1.1% | 1.2% | ▲ 0.1 pts |
| Return on equity (ROE) | 10.0% | 18.5% | 16.1% | 14.9% | 14.2% | ▼ 0.8 pts |
Price history is added with the daily price update and will appear after the next one.